Medical/Pharmaceuticals
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
SHANGHAI, Dec. 22, 2021 /PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma ("Nuance"), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an exclusive a...
2021-12-23 07:44
3567
LINEPHARMA INTERNATIONAL FILES FOR MANUFACTURING, MARKETING APPROVAL OF THE ABORTION PILL IN JAPAN
LONDON and TOKYO, Dec. 23, 2021 /PRNewswire/ -- Linepharma International Ltd., a global leader in medical abortion, announced today that its subsidiary Linepharma KK has applied for manufacturing and marketing approval inJapan for its oral drug MEFEEGO™ for the medical termination of pregnancies ...
2021-12-23 05:57
3609
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
- Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants - Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG rise...
2021-12-23 05:54
4573
Steri-Tech Chooses CleanAir Engineering's Picarro-Based Ethylene Oxide Solution for Multi-Point Indoor Air Quality Monitoring at Commercial Sterilization Facility
Combination of Advanced Technology and Turn-Key Solutions Will Enable Accurate Ethylene Oxide Emissions Quantification and Aid in Promoting a Safer Sterilization Process SANTA CLARA, Calif. and PALATINE, Ill., Dec. 22, 2021 /PRNewswire/ -- Steri-Tech, Inc. (Steri-Tech), a Puerto Rican corporatio...
2021-12-22 23:08
3081
Deargen Annonuces Patent Application for a TNBC Target Novel Drug Candidate Using AI
* Using a self-developed AI platform, it takes only 10 weeks from the discovery of the anticancer drug targets to the discovery and synthesis of new compounds. * Proven capabilities for NCE compound discovery and design, and the establishment of a R&D center(iDear Center) to continuously deve...
2021-12-22 22:00
2422
AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in Congenital Myotonic Dystrophy
- Additional research centers now enrolling patients in Australia and New Zealand - Company has achieved 50 percent of target enrollment in global Phase 3 trial LONDON, Dec. 23, 2021 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on r...
2021-12-22 21:00
2311
People-focused Highbrook Medical Centre is Now Officially Open
AUCKLAND, New Zealand, Dec. 22, 2021 /PRNewswire/ -- Highbrook Medical Centre,
the newest of Health Improvement Group'sAuckland clinics, including Botany
Junction
2021-12-22 19:12
1978
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines
* US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology. * LEAP™ enables large-scale, clinical grade commercial production of exosomes needed to underpin the emerging field of exosome medicines. * Exopharm is seeking potential p...
2021-12-22 19:00
2593
HKU teams develop the first anti-COVID-19 stainless steel
HONG KONG, Dec. 22, 2021 /PRNewswire/ -- The project team led by Professor Mingxin HUANG at the Department of Mechanical Engineering of the Faculty of Engineering of theUniversity of Hong Kong (HKU), in collaboration with Professor Leo Lit Man POON's research team at the Centre for Immunity and ...
2021-12-22 18:09
3809
Technology central to sustainability, affordability of global healthcare industry
SINGAPORE, Dec. 21, 2021 /PRNewswire/ -- Healthcare spending saw a steep decline during the COVID-19 pandemic with associated lockdowns, restrictions, and postponement of non-essential treatments. However, the trend is expected to be short-lived as COVID-19 vaccines and testing became widely avai...
2021-12-22 14:25
2961
Wellscare to debut latest IASO-Ultra self-therapy devices at CES 2022
SEOUL, South Korea, Dec. 22, 2021 /PRNewswire/ -- Healthtech startup Wellscare is taking part in theConsumer Electronics Show 2022 (Jan. 5-8, 2022), where it will be showcasing a number of new products, including an upgraded version of its self-therapy device for herniated disk patients, IASO-...
2021-12-22 14:19
3798
TCM provides new alternatives for the fight against COVID-19
BEIJING, Dec. 21, 2021 /PRNewswire/ -- A news report by haiwainet.cn: During the 18th World Congress of Traditional Chinese Medicine held on4 December 2021, experts fromSpain, France, Australia and other countries and regions highly recognized the role of Traditional Chinese Medicine (TCM) in fig...
2021-12-22 10:15
1910
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories
- Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications inEurope (including theUnited Kingdom), Latin America and Other Key Countries - Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202...
2021-12-22 09:39
4365
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine
- WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older - SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emerg...
2021-12-22 09:31
4770
Ortoma Signs Agreement for Exclusive Distribution Rights in Japan
STOCKHOLM, Dec. 22, 2021 /PRNewswire/ -- Ortoma signs agreement with Johnson & Johnson K.K. for exclusive distribution rights inJapan of the Ortoma Treatment Solution for hip surgery. It is the first agreement that the company executes with a global strategic partner. The agreement allows for the...
2021-12-22 09:30
3092
EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization
CHICAGO and KANSAS CITY, Mo., Dec. 21, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition ofIntouch Group®, a full-service global agency network serving the pharmaceutical indust...
2021-12-21 21:15
4658
MSD Romania recognized as one of the Best Workplaces for 2021
BUCHAREST, Romania, Dec. 21, 2021 /PRNewswire/ -- MSD Romania, an affiliate of the American multinational pharmaceutical company developing and producing medicines, vaccines, biologic therapies, animal health products, have been certified as one of the Best Places to Work for 2021. This certifica...
2021-12-21 21:05
2027
Novaliq Announces POSITIVE Topline Results for SECOND PHASE 3 TRIAL (ESSENCE-2) of CyclASol® in Dry Eye Disease
HEIDELBERG, Germany and CAMBRIDGE, Mass, Dec. 21, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evalu...
2021-12-21 21:00
2080
Jolly Good develops a medical VR filming system exclusively for ambulances with physicians
TOKYO, Dec. 21, 2021 /PRNewswire/ -- Jolly Good Inc. ("Jolly Good") developed a medical VR filming system for ambulances with physicians in collaboration with Nippon Medical School Hospital Emergency & Critical Care Medicine (Bunkyo-ku, Tokyo; Director: Shoji Yokobori). Together, they will begin t...
2021-12-21 21:00
2064
Ping An Good Doctor and Chugai Pharma China Jointly Establish a Whole Course Management System for Osteoporosis Patients
HONG KONG and SHANGHAI, Dec. 21, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 1833.HK) announced that it had entered into a strategic partnership with a leading Japanese pharmaceutical company, Chugai Pharma China Co., Ltd., ("Chugai P...
2021-12-21 17:57
3760
Week's Top Stories
Most Reposted
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 313 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 301 media titles]
2026-08-06 15:10
GCash Parent Mynt Cited as Sole Philippine Firm in World's Top Fintech Companies List
[Picked up by 296 media titles]
2026-08-12 16:02
Two CityUHK scholars elected to the European Academy of Engineering in recognition of their internationally acclaimed research achievements
[Picked up by 294 media titles]
2026-08-10 19:12
MetaOptics Ltd achieves 79% of FY2025 full-year revenue in 1H 2026, on track to fulfil purchase orders of key metalens production equipment in 2H 2026
[Picked up by 293 media titles]
2026-08-11 19:03Most Read
Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
2026-08-06 15:10
19551
AMTD IDEA's Receipt of NYSE Letter Regarding ADS Trading Price's Below Compliance Standards
2026-08-08 04:01
13745
China Yuchai International Announces Unaudited 2026 First Half-Year Financial Results
2026-08-07 18:00
13492